Search clinical trials for: Lenalidomide (Revlimid®)
Total 14688 results
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.CompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Mayo ClinicElgene ChemicalCompletedComplex Regional Pain Syndrome, Type 1United States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
Heinrich-Heine University, DuesseldorfCelgene CorporationCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicGermany
-
University of Colorado, DenverCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Stanford UniversityCelgene CorporationTerminatedLeukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated
-
Yale UniversityCelgene; Kyowa Kirin Co., Ltd.Completed
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
Case Comprehensive Cancer CenterTerminatedRectal Cancer | Colon CancerUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Mayo ClinicNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterCelgeneTerminatedMalignant GliomasUnited States
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
University Health Network, TorontoCelgene Corporation; Otsuka Pharmaceutical Development & Commercialization,... and other collaboratorsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Stage I Small Lymphocytic LymphomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminatedWaldenstrom MacroglobulinemiaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of NebraskaNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Geron CorporationCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Grupo Español de Linfomas y Transplante Autólogo...Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, IncCompleted
-
Brian HillThe Cleveland ClinicTerminatedLymphoma | B Cell LymphomaUnited States
-
Celgene CorporationCompletedNewly Diagnosed Multiple MyelomaSpain, Netherlands, Austria, Australia, Italy, Russian Federation, United Kingdom, Israel, Belgium, Greece, Germany, Poland, Turkey, France, Denmark, Czech Republic, Belarus, Georgia, Ireland, Sweden, Switzerland, Ukraine
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedMyeloproliferative DiseasesUnited States
-
Maria LiljeforsKarolinska University Hospital; Karolinska Institutet; CelgeneCompletedPancreatic Ductal Adenocarcinoma | Pancreatic Carcinoma MetastaticSweden
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer Research...CompletedSmoldering Multiple MyelomaUnited States
-
Mayo ClinicCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
CelgeneCompleted
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Completed
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene; Aduro Biotech, Inc.Active, not recruitingMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
SCRI Development Innovations, LLCCelgene CorporationCompletedMetastatic Pancreatic CancerUnited States
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
CelgeneCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States